Sickle cell disease is a hereditary disease that remains a public health
problem in Mali. Our objective was to study strokes in children with sickle
cell disease aged from 6 months to 15 years in the pediatrics department of the
Gabriel Toure university hospital center. This was a retrospective descriptive
study from April 1, 2019 to March 31, 2021 and prospective from April 1, 2021
to April 30, 2022, i.e. 3 years,
which took place in the Pediatrics department of the Gabriel Toure university
hospital center. During this study, we identified 22 cases of stroke among 714
children with sickle cell disease. The frequency of stroke in this population
is 3.08%. The age group from1 to 5 years was the most affected with 40.9%. The
average age of the patients was 7 years with extremes ranging from 1 year to 15
years and a median of 5 years. The male gender was predominant with 54.5%, for
a sex ratio of 1.2. Headaches were the most common neurological antecedents
(63.5%). Half of the patients were diagnosed with sickle cell disease after the
onset of the stroke. The installation of the deficit was progressive in 54.5%
of cases. Consciousness disorders were the most
frequent reason of consultation (27.2%), followed by convulsions (18.1%). The most common
neurological signs were impaired consciousness and hemiparesis with 45.5% each.
The stroke was ischemic in 100% of cases. There were 95.5% of SS forms and 4.5%
of Sβ0thalassemia forms.
Our patients had a hemoglobin level less than 7g/dl in
57.1% of cases and between 7 and 9
References
[1]
Piel, F.B., Steinberg, M.H. and Rees, D.C. (2017) Sickle Cell Disease. The New England Journal of Medicine, 376, 1561-1573. https://doi.org/10.1056/NEJMra1510865
[2]
Diallo, D.A. (2008) Sickle Cell Disease in Africa: Problems, Strategies for Improving the Survival and Quality of Life of Sickle Cell Patients. Bulletin de l’Académie nationale de médecine, 192, 1361-1373.
[3]
Belala, A., Marc, I., Hajji, A., Belghyti, D. and El Kharrim, K. (2016) Sickle Cell Disease among Children Hospitalized in the Pediatric Department (CHR El Idriss De Kénitra, Morocco): About 53 Cases. European Scientific Journal, 12, 201-210.
[4]
Prengler, M., Pavlakis, S.G., Prohovnik, I. and Adams, R.J. (2002) Sickle Cell Disease: The Neurological Complications. Annals of Neurology, 51, 543-552.
https://doi.org/10.1002/ana.10192
[5]
Guitton, C. (2016) Cerebral Vasculopathy in Children with Sickle Cell Disease. The Letter from the Neurologist, 20, 123-126.
[6]
Thiam, L., Boiro, D., Basse, I., Aidara, C.M., Fall, A.L., N’diaye, M., et al. (2022) Stroke in Children and Adolescents in Ziguinchor/Senegal. Journal de Pédiatrie et de Puériculture, 35, 252-258. https://doi.org/10.1016/j.jpp.2022.03.005
[7]
Ouattara, A. (2010) Cerebrovascular Accidents in Major Sickle Cell Patients Aged 6 Months to 15 Years in the Pediatrics Department of CHU GT. Thesis, FMPOS, Bamako, 47 p.
[8]
Rakotoharimanana, V.C. (2017) Profile of Sickle Cell Patients Presenting with Stroke. Thesis, Faculty of Medicine, Antananarivo, 49 p.
[9]
DeBaun, M.R., Sarnaik, S.A., Rodeghier, M.J., Minniti, C.P., Howard, T.H., Iyer, R.V., et al. (2012) Associated Risk Factors for Silent Cerebral Infarcts in Sickle Cell Anemia: Low Baseline Hemoglobin, Sex, and Relative High Systolic Blood Pressure. Blood, 119, 3684-3690. https://doi.org/10.1182/blood-2011-05-349621
[10]
Lemine, S.O.M., Ndiaye, M., Sow, A.D., Basse, A.M., Seck, L.B., Touré, K., et al. (2013) Sickle Cell Disease Is the Leading Cause of Ischemic Stroke in Children in a Senegalese Series. Archives de Pédiatrie, 20, 423.
[11]
Coulibaly, F.Y. (2015) Cerebral Vasculopathy in Children with Sickle Cell Disease in Mali. These, FMOS, Bamako, 64 p.
[12]
Serra, J.K., Mecili, M., Housni, B. and Andrès, E. (2012) Acute Complications of Sickle Cell Disease in Adults: From Pathophysiology to Treatment. Therapeutic Medicine, 18, 239-250.
[13]
Bernaudin, F. and Verlhac, S. (2008) Cerebrovascular Accidents in Sickle Cell Patients: Contribution of Transcranial Doppler and Magnetic Resonance Imaging. Hematology, 14, 25-35. https://doi.org/10.1007/BF03545573
[14]
Driscoll, M.C., Hurlet, A., Styles, L., MvKie, V., Files, B., Olivieri, N., et al. (2003) Stroke Risk in Siblings with Sickle Cell Anemia. Blood, 101, 2401-2404.
https://doi.org/10.1182/blood.V101.6.2401
[15]
Bernaudin, F. and Verlhac, S. (2020) Sickle Cell Cerebral Vasculopathy. In: De Montalembbert, M., et al., Eds., Sickle Cell Disease in Children and Adolescents, El. Mas, Paris, 138-146.
[16]
Connes, P., Verlhac, S. and Bernaudin, F. (2013) Advances in Understanding the Pathogenesis of Cerebrovascular Vasculopathy in Sickle Cell Anaemia. British Journal of Haematology, 161, 484-498. https://doi.org/10.1111/bjh.12300
[17]
Elion, J., Laurance, S. and Lapouméroulie, C. (2010) Pathophysiology of Sickle Cell Disease. Tropical Medicine, 70, 454-458.
[18]
Basse, A.M., Sow-Sembene, A.D., Youssouf, I., Diop-Sene, M.S., Sarr, M.M., Touré, K., et al. (2014) Epidemiology of Childhood Strokes in Senegal. Journal of Neurosurgery, 20, 5-12.
[19]
Mellouli, F. and Bejaoui, M. (2008) The Use of Hydroxyurea in Severe Forms of Sickle Cell Disease: Study of 47 Tunisian Pediatric Cases. Archives de Pédiatrie, 15, 24-28. https://doi.org/10.1016/j.arcped.2007.09.013
[20]
Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Hau, I., Leveille, E., et al. (2016) Long-Term Treatment Follow-Up of Children with Sickle Cell Disease Monitored with Abnormal Transcranial Doppler Velocities. Blood, 127, 1814-1822.
https://doi.org/10.1182/blood-2015-10-675231
[21]
Bonan, I.V., Raillon, A. and Yelnik, A.P. (2014) Rehabilitation after Stroke. EMC Neurology, 11, 1-10.